“The Integrated 31-Gene Expression Profile Test (i31-GEP) for Cutaneous Melanoma Outperforms the CP-GEP at Identifying Patients who can Forego Sentinel Lymph Node Biopsy when Applying NCCN Guidelines” (2022) SKIN The Journal of Cutaneous Medicine, 6(6), pp. 474–481. doi:10.25251/skin.6.6.4.